RxSight (RXST) Cash from Investing Activities (2020 - 2026)

RxSight's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 57.57% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 104.75% YoY) and the FY2025 annual result came in at $16.9 million, up 117.01% from the prior year.
• Cash from Investing Activities was $8.8 million for Q1 2026 at RxSight, up from -$9.6 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $43.8 million in Q2 2022 and bottomed at -$115.6 million in Q2 2024.
• A 5-year average of -$3.3 million and a median of $4.4 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 2984.82% — and 2024, when it tumbled 2731.29%.
• RxSight's Cash from Investing Activities stood at $10.4 million in 2022, then plunged by 56.12% to $4.6 million in 2023, then slumped by 71.09% to $1.3 million in 2024, then sank by 828.33% to -$9.6 million in 2025, then jumped by 192.03% to $8.8 million in 2026.
• Business Quant data shows RXST's Cash from Investing Activities at $8.8 million in Q1 2026, -$9.6 million in Q4 2025, and -$9.0 million in Q3 2025.